CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test
Are you experiencing symptoms of primary aldosteronism, seizures, or neurologic abnormalities? DNA Labs UAE offers a comprehensive genetic test to help diagnose these conditions and guide appropriate treatment or management strategies. Our CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test is designed to analyze the CACNA1D gene, which is associated with these conditions.
Test Details
The CACNA1D gene is linked to primary aldosteronism, seizures, and neurologic abnormalities. Primary aldosteronism is characterized by the overproduction of aldosterone hormone, leading to high blood pressure and low potassium levels. Seizures are abnormal electrical activity in the brain that can cause changes in behavior, movements, or consciousness. Neurologic abnormalities refer to any dysfunction or abnormality in the nervous system, which can manifest as developmental delays, movement disorders, or cognitive impairments.
Our Next-Generation Sequencing (NGS) technology allows us to analyze multiple genes simultaneously to identify genetic variations or mutations. In the case of the CACNA1D gene, our NGS genetic testing can identify any variations or mutations that may be associated with primary aldosteronism, seizures, or neurologic abnormalities.
Test Components and Price
Our CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test is priced at AED 4400.0. The test can be conducted using a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
Once the test is conducted, the report will be delivered within 3 to 4 weeks. Our method of analysis is NGS technology, ensuring accurate and comprehensive results.
Referring Doctor and Test Department
If you are considering this test, we recommend consulting with a General Physician. Our test department specializes in Genetics and will ensure the highest quality of analysis and interpretation.
Pre Test Information and Genetic Counselling
Before undergoing the CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by these conditions. This will aid in the accurate interpretation of the test results and provide valuable insights into the genetic factors involved.
Don’t wait any longer to find answers to your symptoms. Contact DNA Labs UAE today to schedule your CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test and take control of your health.
Test Name | CACNA1D Gene Primary aldosteronism seizures and neurologic abnormalities Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CACNA1D Gene Primary aldosteronism, seizures, and neurologic abnormalities NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1D Gene Primary aldosteronism, seizures, and neurologic abnormalities NGS Genetic DNA Test gene CACNA1D |
Test Details |
The CACNA1D gene is associated with primary aldosteronism, seizures, and neurologic abnormalities. Primary aldosteronism is a condition characterized by the overproduction of aldosterone hormone by the adrenal glands, leading to high blood pressure and low potassium levels. Seizures are episodes of abnormal electrical activity in the brain that can cause changes in behavior, movements, or consciousness. Neurologic abnormalities refer to any abnormality or dysfunction of the nervous system, which can manifest as developmental delays, movement disorders, or cognitive impairments. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations. In the context of the CACNA1D gene, NGS genetic testing can be used to identify any variations or mutations in this gene that may be associated with primary aldosteronism, seizures, or neurologic abnormalities. This can help in diagnosing these conditions and guiding appropriate treatment or management strategies. |